#ATA2025 highlights 🦋: active surveillance/ablation for ≤1 cm low-risk tumors, updated Tg cutoffs and de-escalation in follow-up, neoadjuvant RET-targeted therapy, AI-enhanced ultrasound, immunotherapy advances, and care disparities spotlighted. 🙌 @AmThyroidAssn

CAREER NEWS: Happy to share I have joined the @universityofky.bsky.social @ukhealthcare.uky.edu in beautiful 🐎 Lexington KY, where I'll have the privilege of leading the #ThyroidCancer Program @ukmarkey.bsky.social & continue my passion for #MedEd serving as endo fellowship APD #GoWildcats 😺

After 7 incredible years, I’m saying goodbye to @MayoClinic @MayoClinicHS. Grateful for the mentorship, growth, and countless lessons that shaped me into the doc I am today. This is a place that challenged and prepared me well for what’s next and I am so thankful @MayoClinicEndo

🧵 The USPSTF's latest guidelines on screening for #osteoporosis now defines screening as a specific method of x-ray bone density testing.

JAMA provides clinicians with essential resources to understand & implement these updated guidelines.

ja.ma/4aoKGWE

#MedSky

Ringing in the new year with publication in Endocrine Practice!
Our study🔍 introduces a predictive model for Graves' disease recurrence after antithyroid therapy 💊, featuring a nomogram for bedside clinical use. 🏥 (thread ⬇️)

tinyurl.com/58uufx3u

#GravesDisease #Endocrinology #PrecisionMedicine